Prevalence of HIV-1 drug resistance among patients failing first-line ART in Monrovia, Liberia: a cross-sectional study | Zendy

Paul Loubet | Zendy; Charlotte Charpentier | Zendy; Benoît Visseaux | Zendy; Abraham Borbor | Zendy; Cecilia Nuta | Zendy; Eric Adu | Zendy; Jean-Marc Chapplain | Zendy; Maima Baysah | Zendy; Pierre Tattevin | Zendy; Yazdan Yazdanpanah | Zendy; Diane Descamps | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prevalence of HIV-1 drug resistance among patients failing first-line ART in Monrovia, Liberia: a cross-sectional study

Author(s) -

Paul Loubet,

Charlotte Charpentier,

Benoît Visseaux,

Abraham Borbor,

Cecilia Nuta,

Eric Adu,

Jean-Marc Chapplain,

Maima Baysah,

Pierre Tattevin,

Yazdan Yazdanpanah,

Diane Descamps

Publication year - 2015

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkv030

Subject(s) - efavirenz , medicine , nevirapine , abacavir , lamivudine , stavudine , zidovudine , etravirine , drug resistance , virology , emtricitabine , reverse transcriptase inhibitor , viral load , rilpivirine , human immunodeficiency virus (hiv) , viral disease , antiretroviral therapy , virus , hepatitis b virus , biology , microbiology and biotechnology

To assess the prevalence of acquired drug resistance in HIV-1-infected patients living in Monrovia, Liberia, who had clinical and/or immunological failure of first-line ART according to WHO criteria.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research